| Jahr | Publikation |
| 2021 | Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Majek O, Muzik J, Nilbert MC, Tybjerg AJ, Innos K, Mägi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincerzevskiene I, Lemmens V, Elferink MAG, Johannesen TB, Korner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, Zagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021. |
| 2021 | Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B, Martus P, Flatz L, Leiter U, Whiteman D.
Eur J Cancer. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. 2021 May 29;152:18-25. |
| 2021 | Gieseler F, Heidenreich A, Schubert J, Frielitz F, Rehmann-Sutter C, Wörler F, Schües C, Hübner J, Elsner S, Block K, Rody A, von Bubnoff N, Keck T, Steimann M, Endsin G, Katalinic A. The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making". Health science reports. 2021;4(2):e281 |
| 2021 | Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Psychosocial and family-centered support among breast cancer patients with dependent children. Psychooncology. 2021;30(3):361-8. |
| 2021 | Krensel M, Petersen J, Stephan B, Katalinic A, Augustin J. Vergleich der Patientenpfade bei der Früherkennungsuntersuchung auf Hautkrebs – eine Sekundärdatenanalyse. J Dtsch Dermatol Ges. 2021;19(3):389-99 |
| 2021 | Lillini R, Tittarelli A, Bertoldi M, Ritchie D, Katalinic A, Pritzkuleit R, Launoy G, Launay L, Guillaume E, Žagar T, Modonesi C, Meneghini E, Amati C, Di Salvo F, Contiero P, Borgini A, Baili P. Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review. Reviews of environmental contamination and toxicology. 2021 |
| 2021 | Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes. Breast care (Basel, Switzerland). 2021;16(2):163-72 |
| 2021 | Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3?years from diagnosis in Europe. Int J Cancer. 2021 |
| 2020 | Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. 2020;82(S 01):62-71. |
| 2020 | Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Res. 2020;30(4):386-95. |
| 2020 | Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer. Breast Care. 2020;15(2):163-70. |
| 2020 | Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany. Geburtsh Frauenheilk. 2020;80(6):611-8. |
| 2020 | Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 2020;12(9). |
| 2020 | Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sanchez MJ, Bielska-Lasota M, Rossi PG, Sant M. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. 2020;46(6):1151-9. |
| 2020 | Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020. |
| 2020 | Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Int J Cancer. 2020. |
| 2019 | Brunßen A, Eisemann N, Hübner J, Katalinic A. Aktuelle Evidenz zum Nutzen des Hautkrebs-Screenings. In: Günster C, Klauber J, Robra BP, Schmacke N, Schmucker C, editors. Versorgungs-Report Früherkennung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 2019. p. 191-207. |
| 2019 | Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histological subtype. J Am Acad Dermatol. 2019;80(4):938-46. |
| 2019 | Deck R, Babaev V, Katalinic A. [Reasons for the Non-Utilisation of an Oncological Rehabilitation. Results of a Written Survey with Patients of Oncological Healthcare Centers]. Reha. 2019;58(4):243-52. |
| 2019 | Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, Martus P, Leiter U. Time trends in incidence and mortality of cutaneous melanoma in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019;33(7):1272-80. |
| 2019 | Gieseler F, Schäfer V, Rody A, Katalinic A, Maass N, Strohscheer I, Jürgensen M. Adherence of Older Breast Cancer Patients to Cancer Therapy Recommendations. Diversity and Equality in Health and Care. 2019;16(1):11-7. |
| 2019 | Hübner J, Hübner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017]. Hautarzt. 2019;70(12):989-92. |
| 2019 | Hübner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. 2019;34(4):599-605. |
| 2019 | Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2019. |
| 2019 | Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany. BMC Health Serv Res. 2019;19(1):786. |
| 2019 | Rudolph CES, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects]. Gesundheitswesen. 2019;81:993-1000. |
| 2018 | Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166-8. |
| 2018 | Hübner J, Eisemann N, Brunßen A, Katalinic A. Hautkrebsscreening in Deutschland: Bilanz nach zehn Jahren. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2018;61(12):1536-43. |
| 2018 | Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Eur J Cancer Prev. 2018;27(6):563-9. |
| 2018 | Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H, Workgroup GCS. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral oncology. 2018;76:8-15. |
| 2018 | Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Zagar T, Bielska-Lasota M, Rossi PG, Larranaga N, Bastos J, Sanchez MJ, Sant M. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2018;144(9):2118-27. |
| 2018 | Pritzkuleit R, Katalinic A. Sozioökonomischer Status und Krebs. Public Health Forum. 2018;26(4):372-5. |
| 2018 | Pulte D, Weberpals J, Schroder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer. 2018;143(2):324-32. |
| 2018 | Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Laronningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadottir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018;92:108-18. |
| 2018 | Swetter SM, Geller AC, Leachman SA, Kirkwood JM, Katalinic A, Gershenwald JE. Melanoma Prevention and Screening. In: Balch C, al. e, editors. Cutaneous Melanoma. Cham: Springer; 2019. |
| 2018 | Wöckel A, Festl J, Stuber T, Brust K, Stangl S, Heuschmann PU, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kuhn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, Konig K, Hahne A, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Luftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Muller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Holzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmuller S, Sinn HP, Dunst J, Munstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching PA, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Kobrunner S, Huober J, Hubner J, Jackisch C, Loibl S, Luck HJ, von Minckwitz G, Mobus V, Muller V, Nothlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schutz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bucker A, Krockenberger M. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer. Geburtshilfe Frauenheilkd. 2018;78(10):927-48. |
| 2017 | Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review. J Am Acad Dermatol. 2017;76(1):129-39 e10. |
| 2017 | Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 2017;141(11):2270-80. |
| 2017 | Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. 2017;20(1):61-6. |
| 2017 | Holleczek B, Katalinic A. Toward a comprehensive cancer registration in Germany. Eur J Cancer Prev. 2017;26:S132-S8. |
| 2017 | Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma. Br J Cancer. 2017;116(2):253-9. |
| 2017 | Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C. Incidence, Mortality and Trends of Non-Melanoma Skin Cancer in Germany. J Invest Dermatol. 2017;137(9):1860-7. |
| 2017 | Noftz MR, Hübner J, Katalinic A. Früherkennung bei Brustkrebs. Onkologe. 2017;5. |
| 2017 | Pritzkuleit R, Katalinic A, Gieseler F. Krebsregister und Gesundheitswesen. Anfragen bei Verdacht auf Krebshäufungen, Erwartungen und Befürchtungen. Onkologe. 2017;23(4). |
| 2017 | Pritzkuleit R, Katalinic A. Demografische Entwicklung. In: Willkomm M, editor. Praktische Geriatrie Klinik - Diagnostik - Interdisziplinäre Therapie 2, vollständig überarbeitete und erweiterte Auflage. Stuttgart - New York: Georg-Thieme-Verlag; 2017. p. 119-22. |
| 2017 | Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. Eur J Cancer. 2017;84:81-7. |
| 2017 | Schmick A, Juergensen M, Rohde V, Katalinic A, Waldmann A. Assessing health-related quality of life in urology - a survey of 4500 German urologists. BMC Urol. 2017;17(1):46. |
| 2017 | Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States in the early 21st century. Haematologica. 2017;102(6):e229-e32. |
| 2016 | Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. 2016;52:102-8. |
| 2016 | Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Ärztebl Int. 2016;113(7):101-6. |
| 2016 | Brunssen A, Hübner J, Katalinic A, Noftz M, Waldmann A. Breast Cancer Epidemiology. In: Jatoi I, Rody A, editors. Management of Breast Diseases 2. Aufl. ed. Schweiz: Springer Verlag; 2016. p. 125-37. |
| 2016 | Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, Gekid Cancer Survival Working Group. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 2016;6:22084. |
| 2016 | Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, Group GCSW. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778-85. |
| 2016 | Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2016;34(2):93-101. |
| 2016 | Heywang-Kobrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). Eur Radiol. 2016;26(2):342-50. |
| 2016 | Katalinic A. Improved prognosis for symptom-free older women with mammography-detected breast cancer? Strahlenther Onkol. 2016;192(2):130-2. |
| 2016 | Liu L, O'Donnell P, Sullivan R, Katalinic A, Moser L, de Boer A, Meunier F, Scientific, Organizing C. Cancer in Europe: Death sentence or life sentence? Eur J Cancer. 2016;65:150-5. |
| 2016 | Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer. 2016;62:1-8. |
| 2016 | Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011. Eur Arch Otorhinolaryngol. 2016;273(6):1481-7. |
| 2016 | Pritzkuleit R, Katalinic A. Demografische Entwicklung und Krebsentwicklung in Deutschland. In: Keck T, Hopt UT, editors. Onkologische Chirurgie bei alten Patienten. Berlin, Heidelberg: Springer-Verlag; 2016. p. 3-11. |
| 2016 | Pritzkuleit R, Katalinic A. Epidemiologie von Krebs im jungen Erwachsenenalter. Forum. 2016. |
| 2016 | Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):28. |
| 2016 | Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer. 2016;139(6):1289-96. |
| 2016 | Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas. 2016;45(6):908-14. |
| 2015 | Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. 2015;30(10):1485-91. |
| 2015 | Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, Group GCSW. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer letters. 2015;369(1):152-66. |
| 2015 | Deck R, Walther AL, Staupendahl A, Katalinic A. [Limitations of Social Participation in General Population - Normative Data of the IMET based on a Population-Based Survey in Northern Germany]. Reha. 2015;54(6):402-8. |
| 2015 | Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, Group GSW. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung cancer. 2015;90(3):528-33. |
| 2015 | Eisemann N, Nolte S, Schnoor M, Katalinic A, Rohde V, Waldmann A. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study. BMC Urol. 2015;15:28. |
| 2015 | Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2015. |
| 2015 | Eisemann N, Waldmann A, Garbe C, Katalinic A. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med Decis Making. 2015;35(2):243-54. |
| 2015 | Fick EM, Katalinic A, Waldmann A. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany. Cancer Research and Treatment. 2015;47(4):747-56. |
| 2015 | Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, Katalinic A, Brabant G. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma - a registry based study in Northern Germany. Eur J Endocrinol. 2015;173(2):139-48. |
| 2015 | Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol. 2015. |
| 2015 | Haug U, Katalinic A. Familiäres Kolonkarzinomrisiko – überschätzt oder real? Gastroenterologe. 2015;10(1):17-20. |
| 2015 | Haug U, Rosch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. [Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges]. Gesundheitswesen. 2015;77(11):869-74. |
| 2015 | Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 2015;136(11):2649-58. |
| 2015 | Katalinic A, Eisemann N, Waldmann A. Hautkrebsscreening in Deutschland. Dtsch Ärztebl. 2015;112(38):629-34. |
| 2015 | Katalinic A, Eisemann N, Waldmann A. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013. Dtsch Ärztebl Int. 2015;112(38):629-34. |
| 2015 | Katalinic A, Fauteck H. QuaMaDi: Eine Erfolgsbilanz. Nordlicht aktuell. 2015;18(6):16-7. |
| 2015 | Katalinic A. Krebsfrüherkennung - Sinn oder Unsinn? Oncol Res Treat. 2015;38(Suppl 3):12. |
| 2015 | Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, Waldmann A. The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up. Dtsch Ärztebl Int. 2015;112(35-36):577-84. |
| 2015 | Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, Waldmann A. Versorgung primärer Mammakarzinome bei älteren Frauen mit adjuvanter Therapie. Dtsch Ärztebl. 2015;112(35-36):577-84. |
| 2015 | Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015. |
| 2015 | Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788-97. |
| 2015 | Sant M, Chirlaque Lopez MD, Agresti R, Sanchez Perez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi S, Siesling S, Minicozzi P, Group E-W. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer. 2015. |
| 2015 | Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Hollander NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2015;51(9):1188-98. |
| 2014 | Breitbart EW, Choudhury K, Anders MP, Volkmer B, Greinert R, Katalinic A, Tacke J, Keilholz U. Benefits and risks of skin cancer screening. Oncol Res Treat. 2014;37(Suppl 3):38-47. |
| 2014 | Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):8. |
| 2014 | Eisemann N, Waldmann A, Katalinic A. Inzidenz des malignen Melanoms und Veränderung der stadienspezifischen Inzidenz nach Einführung eines Hautkrebsscreenings in Schleswig-Holstein. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(1):7. |
| 2014 | Eisemann N, Waldmann A, Rohde V, Katalinic A. Quality of life in partners of patients with localised prostate cancer. Qual Life Res. 2014;23(5):1557-68. |
| 2014 | Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges. Gesundheitswesen. 2014. |
| 2014 | Hübner J, Noftz MR, Schnoor M, Katalinic A. Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling. Internist (Berl). 2014;55(10):1171-81. |
| 2014 | Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H, GEKID Cancer Survival Working Group. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 2014;134(12):2951-60. |
| 2014 | Kapsimalakou S, Waldmann A, Katalinic A, Grande-Nagel I, Fischer D, Barkhausen J, Vogt FM. Follow-up of probably benign lesions in non-screening breast diagnostics. Arch Gynecol Obstet. 2014;290(3):543-51. |
| 2014 | Katalinic A, Waldmann A, Augustin M, Breitbart E, Eisemann N. Evidenz für ein Hautkrebsscreening. Onkologe. 2014;20(6):535-42. |
| 2014 | Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century. Br J Haematol. 2014;164(6):851-7. |
| 2014 | Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554. |
| 2014 | Stabenow R, Katalinic A, Wilsdorf-Köhler H. Stärkung der Zusammenarbeit klinischer und epidemiologischer Krebsregister. Forum. 2014;29(1):7. |
| 2014 | Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Holländer NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2014. |
| 2013 | Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer – Current Figures and Trends. Geburtsh Frauenheilk. 2013;73(2):130–5. |
| 2013 | Fick E-M, Anzeneder T, Katalinic A, Waldmann A. Bisphosphonate und ihre Rolle in der Therapie des Mammakarzinoms – Ergebnisse aus der Biobank PATH. Senologie. 2013;10(4):236-45. |
| 2013 | Greiner F, Nolte S, Waldmann A, Katalinic A, Breitbart EW. Erfassung und Verarbeitung von persönlichen Daten zur Evaluation von Krebsfrüherkennungsprogrammen – Ergebnisse einer Bevölkerungsbefragung im Kontext des Krebsfrüherkennungs- und -registergesetzes. Gesundheitswesen. 2013;75(11):751-3. |
| 2013 | Katalinic A, Richter A, Babaev V, Pritzkuleit R. Krebsregistrierung im europäischen und nichteuropäischen Ausland. Was können wir lernen? Onkologe. 2013;19:1025–36 |
| 2013 | Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415. |
| 2013 | Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718-24. |
| 2013 | Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One. 2013;8(7):e68077. |
| 2013 | Pritzkuleit R, Fauteck H, Katalinic A. Epidemiologische Grundlagen der Onkologie. best practice onkologie. 2013;8(2):6-14. |
| 2013 | Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries (GEKID). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. 2013;37(4):370-3. |
| 2013 | Schnoor M, Hallof A, Hergert-Lüder D, Katalinic A, Waldmann A. Gründe für die Nicht-Teilnahme am Mammographie-Screening – eine Querschnittsuntersuchung aus Schleswig-Holstein. Dtsch Med Wochenschr. 2013;138(45):2289-94. |
| 2013 | Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol. 2013;37(4):492-7. |
| 2013 | Waldmann A, Anzeneder T, Katalinic A. Patients and Methods of the PATH Biobank – A Resource for Breast Cancer Research. Geburtshilfe Frauenheilkd. 2014;74(4):361-9. |
| 2013 | Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours – Current Data and Epidemiological Trends. Geburtsh Frauenheilk. 2013;73(2):123–9. |
| 2013 | Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC qlq-c30 for the german population: a population-based survey. PLoS One. 2013;8(9):e74149. |
| 2013 | Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, Møller H, Siesling S, Comber H, Katalinic A, Rosso S, Eurocourse WP3 Working Group. Economic evaluation of cancer registration in Europe. J Registry Manag. 2014;41(1):31-7. |
| 2012 | Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201-11. |
| 2012 | Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev. 2012;22(1):9. |
| 2012 | Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer. 2012;12(1):128. |
| 2012 | Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A, GEKID Survival Working Group. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. 2012;167(3):7. |
| 2012 | Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany. Community Dent Health. 2012;29(4):6. |
| 2012 | Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51:9. |
| 2012 | Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. 2012;27(9):5. |
| 2012 | Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E. Does Skin Cancer Screening Save Lives? - An Observational Study Comparing Trends in Melanoma Mortality in Regions With and Without Screening. Cancer. 2012;118(21):8. |
| 2012 | Katalinic A, Waldmann A. Brustkrebs sicher und früh diagnostiziert – fast immer geheilt? Geburtsh Frauenheilk. 2012;72:3. |
| 2012 | Kraywinkel K, Wolf U, Katalinic A. Hautkrebs - Epidemiologie und Früherkennung. 2. ed. Bundesamt für Strahlenschutz (BfS) BfRB, Robert Koch-Institut (RKI), Umweltbundesamt (UBA), editor. Berlin: Umweltbundesamt; 2012. 30-4 p. |
| 2012 | Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H, Group GCSW. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up. Eur J Cancer Prev. 2012;22(3):5. |
| 2012 | Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012;106:6. |
| 2012 | Perl M, Waldmann A, Pritzkuleit R, Katalinic A. Zeitlicher Verlauf der Lebensqualität nach Prostatakarzinom [Temporal changes in quality of life after prostate carcinoma]. Urologe. 2012;5(5):7. |
| 2012 | Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, the GCSWG. Survival of non-Hodgkin lymphoma patients in Germany in the early 21st century Leukemia & lymphoma. 2012;54(5):7. |
| 2012 | Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A. Population-based hormone receptor-specific incidence trends of breast cancer in Germany. Maturitas. 2012;73(2):6. |
| 2012 | Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: Stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol. 2012;36:4. |
| 2012 | Siewert U, Hoffmann W, Fendrich K, Katalinic A, Pritzkuleit R. Demographische Herausforderung und Zukunft der onkologischen Versorgung. Onkologe. 2012;18(2):11. |
| 2012 | Waldmann A, Adrich S, Eisemann N, Fauteck H, Grande-Nagel I, Schaefer FK, Vorkefeld M, Warnecke C, Weidner K, Wilke C, Katalinic A. [Structure and process quality of quality-assured mamma diagnostics in Schleswig-Holstein]. Röfo. 2012;184(2):113-21. |
| 2012 | Waldmann A, Kapsimalakou S, Katalinic A, Grande-Nagel I, Stoeckelhuber BM, Fischer D, Barkhausen J, Vogt FM. Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women. Eur Radiol. 2012;22(5):9. |
| 2012 | Waldmann A, Nolte S, Geller AC, Katalinic A, Weinstock MA, Volkmer B, Greinert R, Breitbart EW. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Arch Dermatol. 2012;148(8):8. |
| 2012 | Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 2012;106(5):5. |
| 2011 | Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database. Am J Epidemiol. 2011. |
| 2011 | Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. 2011;284(1):169-74. |
| 2011 | Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 2011;11:129. |
| 2011 | Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Dore JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schuz J, Tucker MA, Volkmer B, Breitbart E. A nationwide population-based skin cancer screening in Germany: Proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. 2010;34(3):355-8. |
| 2011 | Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Tornberg S, Tryggvadottir L. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health. 2011;21(6):686-7. |
| 2011 | Hentschel S, Pritzkuleit R, Schmid-Höpfner S, Katalinic A. Epidemiologische Krebsregistrierung in Deutschland. Aufgaben und aktueller Status. Onkologe. 2011;17(2). |
| 2011 | Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. 2011. |
| 2011 | Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011. |
| 2011 | Obi N, Waldmann A, Schafer F, Schreer I, Katalinic A. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients. Cancer Epidemiol. 2011;35(3):286-92. |
| 2011 | Waldmann A, Knese M, Küchler T, Katalinic A, Rohde V. PORPUS: Ein kurzer, alltagstauglicher und valider Lebensqualitätsfragebogen zur Erfassung prostataspezifischer Symptome. Journal für Urologie und Urogynäkologie. 2011;18(3):5-10. |
| 2011 | Waldmann A, Nolte S, Pritzkuleit R, Breitbart EW, Katalinic A. Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors. Cancers. 2011;3(2):2316-32. |
| 2010 | Katalinic A, Emrich K, Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M. Häufigkeiten, Trends und regionale Unterschiede von Krebserkrankungen in Deutschland. Prävention. 2010;33(4):99-102. |
| 2010 | Katalinic A, Peters E, Beske F, Pritzkuleit R. Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply. Transfus Med Hemother. 2010;37(3):155-9. |
| 2010 | Peters E, Pritzkuleit R, Beske F, Katalinic A. Demografischer Wandel und Krankheitshäufigkeiten. Eine Projektion bis 2050. Bundesgesundheitsbl. 2010;53(5):417-26. |
| 2010 | Pritzkuleit R, Beske F, Katalinic A. Demographischer Wandel und Krebserkrankungen in der Zukunft. Onkologie. 2010;33 (Suppl 7):19-24. |
| 2010 | Schaefer FK, Waldmann A, Katalinic A, Wefelnberg C, Heller M, Jonat W, Schreer I. Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis-analysis of 102,577 diagnostic procedures. Eur Radiol. 2010;20(5):1085-92. |
| 2010 | Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer. Cancer Epidemiol. 2010;34(1):13-9. |
| 2010 | Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A. Test-Retest Reliabilität des OVIS-Fragebogens - Ein Instrument zur Evaluation der onkologischen Versorgung aus Patientensicht. Gesundheitswesen. 2010;72:707-13. |
| 2009 | Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - Results from the German Network of Cancer Registries. Pathobiology. 2009;76(2):90-7. |
| 2009 | Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany. Breast Care. 2009;4:75-80. |
| 2009 | Katalinic A, Raspe H, Waldmann A. Identifikation von Personen mit familiärem oder hereditärem Darmkrebsrisiko mittels eines Fragebogens zur Familienanamnese. Z Gastroenterol. 2009;47:1125-31. |
| 2009 | Pritzkuleit R, Katalinic A. Räumliche Karzinomanalyse: regionaler Vergleich der Inzidenz kolorektaler Karzinome in Bayern im Zeitraum 2006-2008. Lübeck: Institut für Krebsepidemiologie; 2009. |
| 2009 | Schafmayer C, Buch S, Völzke H, von Schonfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, Sipos B, Henopp T, Catalcali J, Hellmig S, ElSharawy A, Katalinic A, Lerch MM, John U, Fölsch UR, Fändrich F, Kalthoff H, Schreiber S, Krawczak M, Tepel J, Hampe J. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int J Cancer. 2009;124(1):75-80. |
| 2009 | Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. Bevölkerungsbezogene Darmkrebsinzidenz im Zeitraum 2000 bis 2006 - Deuten sich erste Auswirkungen des Koloskopie-Screenings an? Eine gemeinsame Auswertung der Krebsregisterdaten aus Bremen, Hamburg, dem Saarland und Schleswig-Holstein |
| 2009 | Waldmann A, Raspe H, Katalinic A. Darmkrebsrisiko bei familiären und hereditären Risikopersonen unter 55 Jahren. Z Gastroenterol. 2009;47:1052-8. |
| 2009 | Waldmann A, Rohde V, Bremner K, Krahn M, Küchler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reverence men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer. 2009;9. |
| 2008 | Heywang-Köbrunner SH, Schreer I, Heindel W, Katalinic A. Bildgebung für die Brustkrebsfrüherkennung. Dtsch Ärztebl. 2008;105(31-32):541-7. |
| 2008 | Hüppe D, Hartmann H, Felten G, Kemen M, Tannapfel A, Gillessen A, Katalinic A. Die Vorsorgekoloskopie rettet Leben--Ergebnisse der Herner Vorsorgedatei. Z Gastroenterol. 2008;46(2):193-200. |
| 2008 | Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008;107(3):427-30. |
| 2008 | Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - Recruitment of the patients and analysis of the non-participants. BMC Cancer. 2008;8(1):311-23. |
| 2008 | Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. S3-Leitlinien-gerechte Versorgung von Patientinnen mit Mammakarzinom. Aktueller Stand in Schleswig-Holstein. Dtsch Ärztebl. 2008;105(18):337-43. |
| 2007 | Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project). Br J Cancer 2007; 96(1):157-161. |
| 2007 | Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007. |
| 2007 | Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El SA, Conring M, Koschnick M, Schwiedernoch S, Katalinic A, Kremer B, Folsch UR, Krawczak M, Fandrich F, Schreiber S, Tepel J, Hampe J. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 2007. |
| 2007 | Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Raspe H, Katalinic A. [Description of the medical care of younger patients (<65 years) with colorectal cancer in Schleswig-Holstein--are diagnostics and therapy compliant with the actual S3-guidelines?]. Gesundheitswesen 2007; 69(4):216-223. |
| 2007 | Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res 2007; 16(5):767-776. |
| 2006 | Rohde V, Diemer T, Hauck E, Bestmann B, Miller J, Schroder H, Weidner W, Katalinic A. Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003). Urol Int 2006; 77(4):311-316. |
| 2005 | Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording]. Gesundheitswesen 2005; 67(10):729-735. |
| 2005 | Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jockel KH. Incidence of Skin Lymphoma in Germany. Ann Epidemiol 2005. |
| 2004 | Gierspien K, Haartje U, Hentschel S, Katalinic A, Kieschke J. Tumorstadienverteilung in der Zielgruppe für das Mammographie-Screening. Deutsches Ärzteblatt 2004; 101(30):2117-2122. |
| 2004 | Katalinic A. Epidemiologische Krebsregistrierung in Deutschland - Bestandsaufnahme und Perspektiven. Bundesgesundheitsbl 2004; 47(5):422-428. |
| 2003 | Katalinic A, Holzmann M, Kunze U. Abhängigkeit der Tumorstadien von der Vollzähligkeit der Registrierung bei Brustkrebs in einem bevölkerungsbezogenen Krebsregister. Gesundheitswesen 2003; 65(8-9):509-515. |
| 2003 | Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (Epidemiology of skin cancer). BJD 2003;(149):1200-1206. |
